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Introduction
Adult polycystic kidney disease (APKD) is character-
ised by bilateral multiple renal cysts and autosomal
dominant inheritance.1 The gene frequency in the
general population has been estimated to be approxi-
mately 1 in 1000 in western countries1 and is likely
to be similar in Hong Kong.2 The disease usually mani-
fests in the fourth decade of life, when there is renal
enlargement, loin pain, hypertension, haematuria, or
chronic renal failure. Liver cysts are present in approxi-
mately 50% of patients.1,2 Intracranial haemorrhage due
to rupture of a berry aneurysm occurs in approximately
15% of patients.2 Ultrasonography of the kidneys is
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Objective. To study the feasibility of making an early diagnosis of adult polycystic kidney disease by using
genetic linkage analysis in Hong Kong.
Design. Genetic linkage study.
Setting. University teaching hospital, Hong Kong.
Participants. Six members of a Chinese family with a history of adult polycystic kidney disease.
Main outcome measures. The inheritance pattern of adult polycystic kidney disease, as detected by poly-
acrylamide gel electrophoresis of polymerase chain reaction products using radioactively labelled primers
specific to six microsatellite DNA markers that are closely linked to the PKD1 gene on chromosome 16.
Results. Four of the six members of the family studied were shown to be positive for disease-linked markers,
and the inheritance of adult polycystic kidney disease could be traced in this family with a higher degree of
precision (93.7%) using genetic linkage analysis, than could be predicted otherwise.
Conclusion. The success of genetic linkage analysis in providing an early diagnosis of adult polycystic kidney
disease is dependent on having a sufficient number of family members whose disease status has been estab-
lished by imaging methods to allow the disease-linked marker haplotype to be determined. The establishment
of a genetic data bank for families with adult polycystic kidney disease should be considered to maximise the
effectiveness of this diagnostic approach.
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the imaging technique of choice and allows an early
diagnosis of APKD to be made for the first-degree
relatives of an affected individual.3 The early diag-
nosis of APKD and the adequate treatment of its
treatable complications may help to improve the
outcome of these patients.4
Recent studies have shown that APKD is geneti-
cally heterogeneous.5-7 There are at least three genes
involved in this disease. Mutations of the polycystic
kidney disease (PKD1) gene on chromosome 16p13.3
account for approximately 85% to 95% of cases of
APKD.3,5 The PKD1 gene has recently been sequenced,
and the structure of its encoded protein—a complex
molecule called polycystin—has been determined.8,9
The second gene, PKD2, is located in the chromosome
region 4q13-q2310,11 and is defective in most of the non-
PKD1 cases of APKD.5,6 A small number of families
are affected by one or more genes of undetermined
loci and which do not map to either PKD1 or PKD2.7
With the elucidation of the genetic basis of
APKD, it is possible to prevent the disease through
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early presymptomatic diagnosis, genetic counselling,
antenatal diagnosis, and family planning. We are the
first group in Hong Kong to develop a technique that
allows a diagnosis of APKD to be made early and
prenatally. The method and its application are reported
in this paper. Problems that are associated specifically
with this diagnostic approach are discussed.
Methods
Study subjects
The index patient with APKD in this study was a
52-year-old woman who was receiving treatment at
the Queen Mary Hospital. Her spouse and four children
were also recruited after informed consent had been
obtained. The ages of the six family members ranged
from 18 to 60 years. All six subjects underwent an
ultrasonographic examination to detect renal cysts.
Blood collection and DNA extraction
From each subject, 15 to 20 mL of peripheral blood was
collected and transferred to bottles that contained EDTA
as an anticoagulant. The blood was mixed with Ficoll
(Nycomed Pharma AS, Oslo, Norway) and mononuclear
blood cells were isolated by centrifugation. The cells were
digested with proteinase K at 37°C overnight. The DNA
was then extracted using phenol, chloroform, and isoamyl
alcohol. The concentration and purity of the extracted
DNA were determined by measuring the absorbance (A)
of ultraviolet light of wavelengths of 260 nm (A260) and
280 nm (A280). The DNA concentration (in ng/µL) was
estimated by using the formula A260/20, and the value of
A260:A280 ratio was kept between 1.8 and 2.0 to exclude
phenol or protein contamination.
Microsatellite marker analysis
The haplotypes of six microsatellite markers within
and around the PKD1 gene were determined for each
subject. The markers used were SM7,12 CW2,13 AC2.5,14
SM6,13 KG8,15 and D16S521.6 They have polymorphism
information content (PIC) values that range from 0.24
to 0.76 in the local Chinese population (Wong HL,
unpublished data, 1998). The locations of the markers
relative to PKD1 are shown in Fig 1.
The microsatellite markers were amplified by
the polymerase chain reaction (PCR) using specific
primers. The DNA sequences of the primers are shown
Table 1. Primers used in the polymerase chain reaction amplification of six microsatellite markers (arranged according to their prox-
imity to the centromere)
Study Marker Locus Repeat PCR primer
Harris et al12 SM7 D16S283 (AC)
 n
5'-ACATATGTAGTCTTCTGCAGG
5'-ACAAAGAGTGAATCTCTGACAG
Peral et al13 CW2 D16S663 (AC)
 n
5'-GTCTTTCTAGGAATGAAATCAT
5'-ATTGCAGCAAGACTCCATCT
Thompson et al14 AC2.5 D16S291 (AC)
 n
5'-AGTGCTGGGATTACAGGCATGAACC
5'-GCAGCCTCAGTTGTGTTTCCTAATC
Peral et al13 SM6 D16S665 (TG)
n
C(CG)
 n
TGC(GT)
 n
5'-AGCTGGGGTCTCAGGGGAGCT
5'-GCGCACACAGCACTAACACG
Snarey et al15 KG8 - (AC)
 n
5'-CACAGCCAGCTCCGAGGGCCT
5'-GACTCCTCCTGGGGGCTGGCTC
Coto et al6 - D16S521 (AC)
 n
5'-CAGCAGCCTCAGGGTT
5'-GAGCGAGACTCCGTCTAAA
Fig 1. The locations of the markers relative to the
PKD1 gene on the short arm of chromosome 16
D16S521
Telomere
PKD1 (54 kb)KG8
SM6
AC2.5
CW2
SM7
Centromere
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in Table 1. The sense strands of the primers were
end-labelled with [γ-32P]-dATP (Amersham LS Ltd.,
Buckinghamshire, United Kingdom) to a specific
activity of 50 µCi/µg, so that the amplified markers
could be detected by autoradiography. In each re-
action, 0.4 nmol of labelled sense primer and 0.4 nmol
of unlabelled antisense primer were mixed in a final
reaction volume of 20 µL. The PCR commenced with
3 minutes of complete denaturation, followed by repeated
cycles of 1 minute of denaturation, 30 seconds of
annealing, and 1 minute of extension. The exact PCR
conditions are shown in Table 2.
Polyacrylamide gel electrophoresis was used to
resolve the markers according to their molecular
size. The PCR products were mixed with 20 µL of
formamide gel-loading buffer (10 mmol/L EDTA,
0.25% xylene cyanol, and 0.25% bromophenol blue).
Table 2. Polymerase chain reaction conditions used to amplify microsatellite markers
Marker Annealing [Mg2+] Template Taq Polymerase Number of
temperature (°C) (mmol/L) (ng) (U) cycles
SM7 56 1.5 80 0.5 25
CW2 61 2.5 20 1.0 25
AC2.5 68 1.5 20 1.0 35
SM6 65 1.5 20 0.5 35
KG8 70 1.5 40 0.5 25
D16S521 63 1.5 40 0.5 35
Fig 2. Pedigree and genetic linkage analysis of a family with a history of adult polycystic kidney disease
(2a) pedigree of the affected family and haplotypes of the markers SM7, CW2, AC2.5, SM6, KG8, and D16S521 that were identified (Z
denotes the most common allele of the marker determined in a survey of the local population); (2b) auto-radiograms showing the results
from the electrophoretic separation of PCR products amplified using primers specific to the six markers
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The mixture was heated to 95°C for 5 minutes to
denature the PCR product, 5 µL of which were then
loaded onto a 6% denaturing polyacrylamide gel (19:1
ratio of acrylamide to bisacrylamide). The gel was
electrophoresed in Tris-borate-EDTA buffer at 35 W
until the xylene cyanol dye front reached approxi-
mately 5 cm from the bottom of the gel. The gel was
vacuum-dried and exposed to X-ray film (Fuji Co.,
Tokyo, Japan) overnight. The film was then developed
and kept as a permanent record.
Results
The pedigree of the family and the haplotypes of
the panel of markers that were identified are shown in
Figure 2A. There were four affected family members:
subjects Ib, IIa, IIc, and IId. Large renal and liver cysts
constituted a prominent feature in this family. Adult
polycystic kidney disease had been diagnosed in sub-
ject Ib in her 40s. Three of her children aged in their
20s were shown to have APKD by ultrasonography.
Figure 2B shows the autoradiogram of the
genotypes of this family. Subjects Ib, IIa, IIc, and IId
possessed the haplotype of Z-4, Z-2, Z-1, Z, Z+2, and
Z+7 for the markers SM7, CW2, AC2.5, SM6, KG8,
and D16S521, respectively. Results of this genetic
linkage analysis (Fig 2A) showed that it was unlikely
(P=0.063) that APKD was not transmitted with the
marker haplotype that was common to these four
affected individuals (Ib, IIa, IIc, and IId) but was
absent from the unaffected members of this family.
Discussion
Although there is no effective treatment that can de-
crease the rate of cyst progression and renal function
deterioration in APKD, the major complications of
APKD are treatable.16 The presymptomatic diagnosis
of APKD may help in the provision of early treatment
or prevention of complications that may delay the
onset of end-stage renal failure.4 Appropriate genetic
counselling can help families deal with psychological
anxiety and proceed with family planning. The affected
family should also be informed about the availability
of antenatal diagnosis, even though some affected
parents may not consider terminating a pregnancy.
The presymptomatic diagnosis of APKD is mostly
achieved by performing ultrasonography.3 A study
showed that 22% of carriers of mutated PKD1
who were younger than 30 years did not show any
renal cysts.17 The age-dependent manifestation of
APKD thus renders this traditional diagnostic method
less effective in young people. Genetic diagnostic
methods that are independent of the development
of phenotypes can overcome the limitations of
ultrasonography.
In some genetic diseases, such as the thalassaemias
and haemoglobinopathies, it is now easy to establish
the diagnosis antenatally by directly identifying the
genetic defects. The PKD1 gene, on the other hand,
is a large gene that has a 14-kb transcript and three
regions at the 5' end that are highly homologous with
the α-globin genes.8,9 A large proportion of mutations
that are associated with APDK fall within these homo-
logous regions and thus cannot be readily identified.
The realisation that polymorphic microsatellite
markers are closely linked to some inherited diseases
has meant that the PCR amplification of these
markers can be used in the presymptomatic or even
antenatal establishment of the diagnosis.18 The method
requires that several members of an affected family
be studied. In the present study, we used six markers
that were located within and on both sides of the
PKD1 locus on chromosome 16. The choice of
these markers was based on their demonstrated poly-
morphism in the local population and the proximity
of the markers to the PKD1 locus. The marker KG8,
in particular, had a low PIC value and was a marker
of limited usefulness. The coverage of the markers
made this method highly specific, because the chance
of a double crossover occurring would be negligible
owing to the proximity of the markers. Hence, once
the marker haplotype that is associated with APKD
has been determined in an affected family, it can be
used to infer inheritance of the disease in individuals
within the family.
When studying other families affected by APKD,
we encountered some limitations of genetic linkage
analysis. The greatest limitation was often the size
of the family. Having more siblings within a family
generally gives more information about the haplotype.
Increased emigration rates and a tendency to have
smaller families could make the establishment of
the haplotype of the markers more difficult in some
families. Adding to this problem is the genetic hetero-
geneity of APKD. As a result of insufficient data, we
were unable to determine whether a defect of PKD1
was responsible for APKD in some of the families
studied. In the family presented in this study, the prob-
ability of a PKD1 gene defect being responsible was
determined to be 0.9375. A much higher probability
value may be achieved if involvement of the PKD2
gene can be excluded by performing further genetic
linkage analysis using markers that flank PKD2.
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It is possible that better techniques that could
directly identify genetic defects may be developed in
the future. In the mean time, genetic linkage analysis
is a valuable method for the early diagnosis of
APKD. The chance of its successful application
can be increased by the creation of a genetic data
bank for APKD families in Hong Kong. The genetic
material collected from several generations of an
affected family could then provide the necessary
information to allow a diagnosis to be made by
genetic linkage studies.
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